Sanj K Patel - Net Worth and Insider Trading

Sanj K Patel Net Worth

The estimated net worth of Sanj K Patel is at least $3 Million dollars as of 2024-04-19. Sanj K Patel is the CHAIRMAN & CEO of Kiniksa Pharmaceuticals Ltd and owns about 162,311 shares of Kiniksa Pharmaceuticals Ltd (KNSA) stock worth over $3 Million. Details can be seen in Sanj K Patel's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sanj K Patel has not made any transactions after 2024-03-07 and currently still holds the listed stock(s).

Transaction Summary of Sanj K Patel

To

Sanj K Patel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sanj K Patel owns 4 companies in total, including Kiniksa Pharmaceuticals Ltd (KNSA) , Syros Pharmaceuticals Inc (SYRS) , and BioCryst Pharmaceuticals Inc (BCRX) among others .

Click here to see the complete history of Sanj K Patel’s form 4 insider trades.

Insider Ownership Summary of Sanj K Patel

Ticker Comapny Transaction Date Type of Owner
KNSA Kiniksa Pharmaceuticals Ltd 2024-03-07 director & 10 percent owner & Chairman & CEO
SYRS Syros Pharmaceuticals Inc 2016-06-29 director
BCRX BioCryst Pharmaceuticals Inc 2015-09-25 director
ICPT Intercept Pharmaceuticals Inc 2014-02-17 director

Sanj K Patel Latest Holdings Summary

Sanj K Patel currently owns a total of 1 stock. Sanj K Patel owns 162,311 shares of Kiniksa Pharmaceuticals Ltd (KNSA) as of March 7, 2024, with a value of $3 Million.

Latest Holdings of Sanj K Patel

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KNSA Kiniksa Pharmaceuticals Ltd 2024-03-07 162,311 16.87 2,738,187

Holding Weightings of Sanj K Patel


Sanj K Patel Form 4 Trading Tracker

According to the SEC Form 4 filings, Sanj K Patel has made a total of 5 transactions in Kiniksa Pharmaceuticals Ltd (KNSA) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Kiniksa Pharmaceuticals Ltd is the sale of 65,012 shares on March 7, 2024, which brought Sanj K Patel around $1 Million.

Insider Trading History of Sanj K Patel

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sanj K Patel Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sanj K Patel Ownership Network

Ownership Network List of Sanj K Patel

No Data

Ownership Network Relation of Sanj K Patel


Sanj K Patel Owned Company Details

What does Kiniksa Pharmaceuticals Ltd do?

Who are the key executives at Kiniksa Pharmaceuticals Ltd?

Sanj K Patel is the director & 10 percent owner & Chairman & CEO of Kiniksa Pharmaceuticals Ltd. Other key executives at Kiniksa Pharmaceuticals Ltd include Chief Accounting Officer Michael R Megna , Chief Medical Officer John Paolini , and Chief Business Officer Eben Tessari .

Kiniksa Pharmaceuticals Ltd (KNSA) Insider Trades Summary

Over the past 18 months, Sanj K Patel made 2 insider transaction in Kiniksa Pharmaceuticals Ltd (KNSA) with a net sale of 83,336. Other recent insider transactions involving Kiniksa Pharmaceuticals Ltd (KNSA) include a net sale of 96,513 shares made by John Paolini , a net sale of 24,101 shares made by Michael R Megna , and a net sale of 21,959 shares made by Barry D Quart .

In summary, during the past 3 months, insiders sold 108,277 shares of Kiniksa Pharmaceuticals Ltd (KNSA) in total and bought 0 shares, with a net sale of 108,277 shares. During the past 18 months, 225,909 shares of Kiniksa Pharmaceuticals Ltd (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 225,909 shares.

Kiniksa Pharmaceuticals Ltd (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kiniksa Pharmaceuticals Ltd Insider Transactions

No Available Data

Sanj K Patel Mailing Address

Above is the net worth, insider trading, and ownership report for Sanj K Patel. You might contact Sanj K Patel via mailing address: C/o Kiniksa Pharmaceuticals, Ltd., Clarendon House, 2 Church Street, Hamilton D0 Hm11.

Discussions on Sanj K Patel

No discussions yet.